Wednesday, November 5, 2025

Sundial Growers: Analysts Expect Positive EBITDA For Second Quarter

Sundial Growers Inc. (Nasdaq: SNDL) announced that they will be reporting their second quarter financials after the market closes on August 12.

Analysts have a consensus $0.68 12-month price target on the company, via a total of 5 analysts, with 4 analysts having a hold rating, and one analyst has a sell rating. The street high comes from ATB Capital Markets with a $0.80 price target, and the lowest target comes in at a $0.45 price target.

Four analysts have revenue estimates for the second quarter. The mean between all 4 is C$10.12 million; this number has been revised slightly downwards from C$18.45 million at the start of the year. The street high is C$12.08 million while the lowest sits at C$8 million.

Two analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 32.50%, with this number being revised slightly higher from 28.30% at the start of the year. Street high goes to ATB Capital with a 40% estimate and the lowest sits at 25%.

Onto EBITDA estimates, there are currently only 3 analysts who have second quarter EBITDA estimates. The mean is currently C$0.63 million, with this number being higher than at the start of the year. Street high comes in at C$8 million EBITDA estimate and the lowest being a (C$5.6) million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

PMET Resources: Lithium Feasibility Study Sees Economics Tumble

Gold Is Not Rising. Confidence Is Collapsing | Todd “Bubba” Horwitz

IAMGOLD: The Quebec Buying Spree

Recommended

Antimony Resources Sees Bald Hill Potential Double In Latest Technical Report

Altamira Gold Adds Second Drill Rig To Ongoing Exploration Program Targeting Gold Porphyry’s

Related News

Medipharm Labs Receives Price Target Reduction From Canaccord To $1.75

Yesterday, On November 16th, Medipharm Labs (TSX: LABS) reported their third quarter financial results. Reported...

Tuesday, November 17, 2020, 03:37:00 PM

Netflix: Second Quarter Earnings Estimates

Netflix (NASDAQ: NFLX) will be reporting their second quarter financial results on July 20th after...

Tuesday, July 20, 2021, 02:46:00 PM

Jushi Holdings: Canaccord Raises Price Target Following Virginia News

On Saturday, both the Virginia House and Senate approved a recreational cannabis bill, which will...

Tuesday, March 2, 2021, 02:47:00 PM

Aphria: Multiple Analysts Raise Price Targets Following Q2 2021 Results

Yesterday, Aphria Inc (TSX: APHA) (NASDAQ: APHA) reported its second quarter financial results for fiscal...

Friday, January 15, 2021, 09:33:18 AM

Aurora Cannabis: Seven Analysts Slash Price Targets In Wake Of Blowout Fourth Quarter

Earlier this week, Aurora Cannabis (TSX: ACB) (NYSE: ACB) reported their fourth-quarter financials, after having...

Thursday, September 24, 2020, 11:33:00 AM